Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to determine whether a personalized lifestyle intervention focused on diet and physical activity reinforcement is effective in avoiding weight gain in the first months following initiation of subcutaneous insulin pump therapy in type-2 diabetic patients.


Clinical Trial Description

Patients with type 2 diabetes using insulin pump therapy are gaining weight within the first months of treatment. This weight gain could counterbalance the metabolic benefice of insulin pump treatment in improving glycemic control and could lead to treatment dropout. Lifestyle intervention aiming at improving physical activity and diet in type 2 diabetes is known to brought body weight reduction and cardiometabolic improvement. The investigator hypothesized that an intensive, home-based, 6-months diet and physical activity program could prevent the body weight gain associated with insulin pump treatment initiation. The investigator will randomize patients with type 2 diabetes into a "lifestyle intervention" arm or a "usual care" control arm at the time of insulin pump treatment initiation. The primary objective will evaluate body weight change at 6 months after insulin pump treatment initiation. The secondary objectives will evaluate change in glycemic control (HbA1c) and body composition at 6 months. In addition, the retention effect will be assessed on body weight change one year after insulin pump treatment initiation, 6 months after the end of the lifestyle intervention. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02791295
Study type Interventional
Source Icadom
Contact
Status Completed
Phase N/A
Start date October 4, 2016
Completion date March 17, 2021

See also
  Status Clinical Trial Phase
Completed NCT04522882 - Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1 N/A
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Not yet recruiting NCT05185518 - Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes N/A
Recruiting NCT05893797 - A Study of LY8888AX in Participants Using a Connected Insulin Management Platform N/A
Withdrawn NCT04957173 - Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project N/A
Not yet recruiting NCT05317585 - Continuous Glucose Monitor Use in Pregnancy N/A
Completed NCT05372471 - Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes. N/A
Completed NCT05111301 - Control-IQ Technology in Individuals With Type 2 Diabetes N/A
Recruiting NCT04585191 - Reducing Treatment Risk in Older Adults With Diabetes N/A
Recruiting NCT04871438 - Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM) N/A
Completed NCT06060743 - Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management N/A
Completed NCT04005261 - C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes
Terminated NCT03980236 - Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study] N/A
Not yet recruiting NCT06185296 - The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy N/A
Completed NCT03437525 - Peer Support in Diabetes Management - Insulin Peer Support N/A
Active, not recruiting NCT03070106 - Diabetes: Functional Medicine Approach vs. Usual Care N/A
Completed NCT02060916 - Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes Phase 2
Recruiting NCT05785832 - A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes N/A
Recruiting NCT04945070 - INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi Phase 4
Recruiting NCT05795439 - The CARING Study: Creating and Restoring Health Through Nutrition Guidance N/A